XenoMEM
Commercial- Indications
- Wound healing, Hernia repair
Company intelligence / Profile preview
Viscus Biologics develops, manufactures, and supplies medical devices and life science products based on natural polymers and extracellular matrix materials. Their offerings include wound dressings made from decellularized tissues, radiopaque surgical markers such as FibremarX cleared by the FDA for implantable use to mark soft tissues during surgery, solubilized collagen bioinks for bioprinting/drug screening/regenerative medicine applications. The company operates under ISO13485/FDA QSR-compliant quality systems with both commercial-stage products and ongoing preclinical R&D activities.
2 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Viscus Biologics.